| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 03/26/1997 | EP0764157A1 Benzopyrans and their use as therapeutic agents |
| 03/26/1997 | EP0764153A1 Substituted pyrazoles having corticotropin-releasing factor (crf) antagonist activity |
| 03/26/1997 | EP0764152A1 Substituted indolylmethylene-oxindole analogues as tyrosine kinase inhibitors |
| 03/26/1997 | EP0764025A1 Method and medicine for alleviating jet lag |
| 03/26/1997 | EP0723445B1 Analgesic agent and its use |
| 03/26/1997 | EP0695751B1 Agent acting on the central nervous system, process for its preparation and pharmaceutical compositions containing it |
| 03/26/1997 | EP0666854B1 Neuroprotective 3,4-dihydro-2(1h)-quinolone compounds |
| 03/26/1997 | CN1146208A Peptides as therapeutic agents for treatment of auto-immune diseases |
| 03/26/1997 | CN1146156A Means for treating auto-immune diseases and method of treatment |
| 03/26/1997 | CN1145897A New aryl (alkyl) propylamides process for preparing them and pharmaceutical compositions containing them |
| 03/26/1997 | CN1145896A New alkoxyaryl compounds, their process of preparation and pharmaceutical compositions which contain them |
| 03/26/1997 | CN1145895A New amido-ethyl substituted fluorene compound and its prepn. |
| 03/26/1997 | CN1145894A New arylalkyl (thio) carboxamides, processes for preparing them and pharmacetuical compositions containing them |
| 03/26/1997 | CN1145790A Chinese medicine 'Jiaotai'an' |
| 03/26/1997 | CN1145780A Rapidly disintegrating medicinal form of tramadol or tramadol salt |
| 03/26/1997 | CN1034333C Prepn. of imidazopyrazole derivatives as analgesics and anti-inflammatory agents |
| 03/25/1997 | US5614630 Neurotransmitter release modulator |
| 03/25/1997 | US5614609 Serine threonine kinase receptor |
| 03/25/1997 | US5614547 Small molecule inhibitors of rotamase enzyme |
| 03/25/1997 | US5614543 1-(aryloxyalkyl)-3- (heteroaryl) pyrrolidines and related compounds useful as antipsychotics and analgesics |
| 03/25/1997 | US5614536 Substituted N-aminoalkylmethane sulfanilide as antispasmodica |
| 03/25/1997 | US5614532 Quinolone derivatives |
| 03/25/1997 | US5614526 Use of phenoxy-piperzine derivatives |
| 03/25/1997 | US5614521 Nerve growth factor |
| 03/25/1997 | US5614517 Treatment of neurological disorders influenced by gamma-aminobutyric acid receptors |
| 03/25/1997 | US5614516 12-aminopyridazinopyrroloisoquinoline compounds |
| 03/25/1997 | US5614509 Pharmaceutical agents for preventing the development of tolerance during the treatment with benzodiazepine-receptor-binding active ingredients |
| 03/25/1997 | US5614508 Antiischemic agents, alzheimers, stroke or nervous system disorders |
| 03/25/1997 | US5614218 Capsule containing morphine salt |
| 03/25/1997 | US5614208 Methods of treatment using di-linoleoyl-mono-gamma-linolenyl glycerol |
| 03/25/1997 | US5614171 Hydrophilic pharmaceutical composition containing ketoprofen lysine salt for topical use |
| 03/20/1997 | WO1997010244A1 NAPHTHAMIDE DERIVATIVES OF 3 β-AMINO AZABICYCLO OCTANE OR NONANE AS NEUROLEPTIC AGENTS |
| 03/20/1997 | WO1997010240A1 Phenol derivatives with pharmaceutical activity |
| 03/20/1997 | WO1997010239A1 Acid addition salts of 2,3,4,5-tetrahydro-1h-3-benzazepine compounds |
| 03/20/1997 | WO1997010230A1 Diarylalkenylamine derivatives |
| 03/20/1997 | WO1997010229A1 Novel n-aminoalkylfluorenecarboxamides; a new class of dopamine receptor subtype specific ligands |
| 03/20/1997 | WO1997010219A1 Benzimidazole derivatives and their use in the prevention and/or the treatment of bone diseases |
| 03/20/1997 | WO1997010216A1 Substituted hydroisoquinoline derivatives and their use as pharmaceuticals |
| 03/20/1997 | WO1997010212A1 Piperidine compounds as calcium channel blockers |
| 03/20/1997 | WO1997010211A1 Novel human nk3 receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them |
| 03/20/1997 | WO1997010210A1 Tricyclic pyrrolidine derivatives as calcium channel antagonists |
| 03/20/1997 | WO1997009992A1 Lipid extract having anti-inflammatory activity |
| 03/20/1997 | WO1997009973A2 Peripherally active anti-hyperalgesic opiates |
| 03/20/1997 | WO1997009885A1 Compositions and methods of use of mononuclear phagocytes to promote axonal regeneration |
| 03/20/1997 | CA2356097A1 Peripherally active anti-hyperalgesic opiates |
| 03/20/1997 | CA2232262A1 Compositions and methods of use of mononuclear phagocytes to promote axonal regeneration |
| 03/20/1997 | CA2232161A1 Diarylalkenylamine derivatives |
| 03/20/1997 | CA2232082A1 Naphthamide derivatives of 3 .beta.-amino azabicyclo octane or nonane as neuroleptic agents |
| 03/20/1997 | CA2232059A1 Phenol derivatives with pharmaceutical activity |
| 03/20/1997 | CA2232007A1 1-acyl-3-phenyl-3-(3-piperidinopropyl)piperidine derivatives as human nk3 receptor selective antagonists |
| 03/20/1997 | CA2231848A1 Acid addition salts of 2,3,4,5-tetrahydro-1h-3-benzazepine compounds |
| 03/19/1997 | EP0763541A1 11-(Substituted phenyl)-estra-4,9-diene derivatives |
| 03/19/1997 | EP0763535A1 Piperidinylmethyloxazolidin-2-one derivatives, their preparation and their use as pharmacological active CNS compounds |
| 03/19/1997 | EP0763107A1 Pantropic neurotrophic factors |
| 03/19/1997 | EP0763062A1 New opioid peptide analogs with mixed mu agonist/delta antagonist properties |
| 03/19/1997 | EP0763045A1 Haemopoietic maturation factor |
| 03/19/1997 | EP0763038A1 The preparation of nalbuphine having low levels of beta-epimer |
| 03/19/1997 | EP0763037A1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USE THEREOF |
| 03/19/1997 | EP0763036A1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USE THEREOF |
| 03/19/1997 | EP0763034A1 Amide derivatives having 5ht1d-antagonist activity |
| 03/19/1997 | EP0763032A1 Palladium catalyzed ring closure of triazolyl tryptamine |
| 03/19/1997 | EP0763031A1 Piperazine derivatives as 5ht1a antagonists |
| 03/19/1997 | EP0763026A1 Gastrin and cck antagonists |
| 03/19/1997 | EP0763022A1 Phenoxyalkyl substituted piperidines, pyrrolidines, morpholines and thiomorpholines as calcium channel antagonists |
| 03/19/1997 | EP0763021A1 Phenoxyalkyl substituted piperidines, pyrrolidines, morpholines and tiomorpholines as calcium channel antagonists |
| 03/19/1997 | EP0762888A1 Copolymer-1 improvements in compositions of copolymers |
| 03/19/1997 | EP0762885A1 Glial mitogenic factors, their preparation and use |
| 03/19/1997 | EP0762877A1 Meta substituted arylalkylamines and therapeutic and diagnostic uses thereof |
| 03/19/1997 | EP0754302A4 Methods and apparatus for synthesizing labeled combinatorial chemical libraries |
| 03/19/1997 | EP0624087B1 Spray-chilled nabumetone |
| 03/19/1997 | EP0573464B1 Process for preparing trans-piperidine-2,5-dicarboxylates |
| 03/19/1997 | CN1145618A New piperidine derivatives |
| 03/19/1997 | CN1145364A Heterocyclic compounds and their preparation and use |
| 03/19/1997 | CN1145226A Method for treating substance abuse withdrawal |
| 03/19/1997 | CN1145225A Medicament for giving up narcotic drugs and stopping pain and its prepn. |
| 03/18/1997 | US5612379 Benzhydrilsulfinyl acetamide for cardiovascular disorders |
| 03/18/1997 | US5612373 Certain diacyl hydrazine derivatives |
| 03/18/1997 | US5612371 Enzyme inhibitors |
| 03/18/1997 | US5612369 Treatment of arterial and venous thrombotic occlusive disorders, inflammation, cancer, and neurodegenerative diseases |
| 03/18/1997 | US5612368 O-arylmethyl-N-(thio)acylhydroxylamines |
| 03/18/1997 | US5612366 Meso-azacyclic aromatic acid amides and esters as novel serotonergic agents |
| 03/18/1997 | US5612365 Angiotensin II receptor antagonists for the treatment and prophylaxis of coronary heart disease |
| 03/18/1997 | US5612359 Substituted biphenyl isoxazole sulfonamides |
| 03/18/1997 | US5612351 Azabicyclic derivatives of 1,2,3-oxa(or thia)diazole |
| 03/18/1997 | US5612349 Enantiomerically pure hydroxylated xanthine compounds to treat shock symptoms |
| 03/18/1997 | US5612346 Risperidone pamoate |
| 03/18/1997 | US5612344 Administering as antiepileptic, anti-parkinson*s disease, or antiemetic agent; brain damage |
| 03/18/1997 | US5612343 N-[(4-heteroaryl-1-piperazinyl)alkyl]-2,3-naphthalimides and related compounds and their therapeutic utility |
| 03/18/1997 | US5612337 Analgesic compounds for prodrugs |
| 03/18/1997 | US5612331 Tetrahydrocarbazole derivatives as 5-HT1-like agonists |
| 03/18/1997 | CA2036630C 1-phenoxycarbonyl-2-pyrrolidinone derivatives and nootropic agents |
| 03/13/1997 | WO1997009348A2 Orphan receptor |
| 03/13/1997 | WO1997009335A1 Substituted phosphinic compounds and their use as pharmaceuticals |
| 03/13/1997 | WO1997009317A2 Optically active phenyl pyrimidine derivative as analgesic agent |
| 03/13/1997 | WO1997009309A1 4-(cycloalkyl)piperidine and 4-(cycloalkylalkyl)piperidine derivatives, preparation thereof and therapeutical applications thereof |
| 03/13/1997 | WO1997009056A1 Extract of iridaceae and compositions containing such extract |
| 03/13/1997 | WO1997009046A1 Compounds and methods |
| 03/13/1997 | WO1997009032A1 Utilization of an extract of a non photosynthetic filamentary bacterium and composition containing such extract |
| 03/13/1997 | WO1997008960A1 Antistress agents for aquatic animals |
| 03/13/1997 | WO1996040085A3 Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures |